CV Sciences (CVSI) Stock Price, News & Analysis

Company Overview

CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in January 2016. CV Sciences, Inc. was incorporated in 2010 and is based in San Diego, California.

Key Stats

• Today's Range: $0.03 to $0.03
• 50-Day Range: $0.03 to $0.04
• 52-Week Range: $0.03 to $0.10
• Volume: 20,430 shs
• Average Volume: 195,306 shs
• Market Capitalization: $5.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CVSI Stock Analysis - Frequently Asked Questions

How have CVSI shares performed this year?

CV Sciences' stock was trading at $0.0338 at the start of the year. Since then, CVSI stock has decreased by 18.6% and is now trading at $0.0275.
View the best growth stocks for 2025 here.

How were CV Sciences' earnings last quarter?

CV Sciences, Inc. (OTCMKTS:CVSI) released its quarterly earnings data on Thursday, August, 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.03). The firm earned $5.13 million during the quarter, compared to the consensus estimate of $5.12 million. CV Sciences had a negative net margin of 16.24% and a negative trailing twelve-month return on equity of 101.85%.

How do I buy shares of CV Sciences?

Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CV Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CV Sciences investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Charlotte's Web (CWBHF), Cronos Group (CRON), KushCo (KSHB), NVIDIA (NVDA) and Organigram (OGI).

Company Calendar

• Last Earnings: 8/12/2021
• Today: 5/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:CVSI
• Previous Symbol: NASDAQ:CVSI
• CIK: 1510964
• Web: www.cvsciences.com
• Phone: (866) 290-2157
• Fax: 619-876-4321
• Employees: 70
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $3.10 million
• Net Margins: -16.24%
• Pretax Margin: -16.26%
• Return on Equity: -101.85%
• Return on Assets: -29.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.10
• Quick Ratio: 0.28

Sales & Book Value

• Annual Sales: $16 million
• Price / Sales: 0.31
• Cash Flow: $0.02 per share
• Price / Cash Flow: 1.75
• Book Value: $0.02 per share
• Price / Book: 1.36

Miscellaneous

• Outstanding Shares: 184,794,000
• Free Float: 182,392,000
• Market Cap: $5.03 million
• Optionable: Not Optionable
• Beta: 0.70